Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 5
Submit an article Journal homepage
262
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The relation of SF3B1 mutation and intracellular iron in myelodysplastic syndrome with less than 5% bone marrow blasts

Liya MaMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Yingwan LuoMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Lingxu JiangMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Dan ShenBone Marrow Cell Morphological Examination Laboratory, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaView further author information
,
Jianhu LiBone Marrow Cell Morphological Examination Laboratory, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaView further author information
,
Weilai XuMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Chen MeiMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Xinping ZhouMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Yanlin RenMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Li YeMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Chenxi LuMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
,
Jin JieMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; View further author information
&
Hongyan TongMDS Center, Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; Correspondence[email protected]
View further author information
 show all
Pages 1179-1186 | Received 25 Jun 2018, Accepted 01 Sep 2018, Published online: 09 Nov 2018

References

  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.
  • Malcovati L, Cazzola M. Refractory anemia with ring sideroblasts. Best Pract Res Clin Haematol. 2013;26:377–385.
  • Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701–718.
  • Ward AJ, Cooper TA. The pathobiology of splicing. J Pathol. 2010; 220:152–163.
  • Patnaik MM, Lasho TL, Hodnefield JM, et al. SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood. 2012;119:569–572.
  • Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic sf3b1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384–1395.
  • Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–69.
  • Malcovati L, Papaemmanuil E, Bowen DT, et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011;118:6239–6246.
  • Thol F, Kade S, Schlarmann C, et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood. 2012;119:3578–3584.
  • Visconte V, Makishima H, Jankowska A, et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia. 2012;26:542–545.
  • Damm F, Thol F, Kosmider O, et al. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia. 2012;26:1137–1140.
  • Visconte V, Rogers HJ, Singh J, et al. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood. 2012;120:3173–3186.
  • Arber DA, Orazi A, Hasserjian A, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Wei X, Meiting C, Xiaoxia Wang, et al. Clinical Hematological Examination Technology (Version 5). Beijing: People's Medical Publishing House; 2015.
  • Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259.
  • Budczies J, Klauschen F, Sinn BV, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7:e51862.
  • Nikpour M, Scharenberg C, Liu A, et al. The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts. Leukemia 2013;27:889–896.
  • Lin CC, Hou HA, Chou WC, et al. IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Am J Hematol. 2014;89:137–144.
  • Hou HA, Kuo YY, Tang JL, et al. Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. Am J Hematol. 2014;89:181–186.
  • Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia. 2005;19:767–775.
  • Lin CC, Hou HA, Chou WC, et al. SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution. Am J Hematol. 2014;89:E109–E115.
  • Cui R, Gale RP, Xu Z, et al. Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts. Leuk Res. 2012;36:1428–1433.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.